Teza Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Teza Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,484	Closed	-$2.56M	–	766
2023 Q1	$2.56M	Buy	+23,484	New	+$2.6M	0.55%	31
2022 Q4	–	Sell	-6,199	Closed	-$384K	–	755
2022 Q3	$384K	Sell	6,199 -8,757	-59%	-$612K	0.08%	352
2022 Q2	$1.19M	Buy	+14,956	New	+$1.42M	0.46%	43
2021 Q3	–	Sell	-2,556	Closed	-$239K	–	661
2021 Q2	$239K	Buy	+2,556	New	+$235K	0.04%	486
2020 Q2	–	Sell	-13,024	Closed	-$386K	–	575
2020 Q1	$386K	Buy	+13,024	New	+$441K	1.23%	24
2019 Q1	–	Sell	-12,216	Closed	-$239K	–	472
2018 Q4	$239K	Buy	+12,216	New	+$239K	0.09%	284
2018 Q3	–	Sell	-65,318	Closed	-$1.08M	–	613
2018 Q2	$1.08M	Buy	+65,318	New	+$996K	0.16%	190

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Teza Capital Management's HZNP Position: Q2 2023 in Review

Teza Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 23,484 shares — an estimated $2.56M sold.

Teza Capital Management first reported a position in HZNP in Q2 2018 and held it in 7 quarters. The position peaked at $2.56M in Q1 2023. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Teza Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Teza Capital Management sold 23,484 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $2.56M.
Teza Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 7 quarters.
Teza Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.56M in Q1 2023.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Teza Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.